John David Harris - Net Worth and Insider Trading
John David Harris Net Worth
The estimated net worth of John David Harris is at least $18 dollars as of 2024-11-13. John David Harris is the VP and GM Cell Therapy of Plus Therapeutics Inc and owns about 14 shares of Plus Therapeutics Inc (PSTV) stock worth over $18. Details can be seen in John David Harris's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John David Harris has not made any transactions after 2016-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John David Harris
John David Harris Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John David Harris owns 1 companies in total, including Plus Therapeutics Inc (PSTV) .
Click here to see the complete history of John David Harris’s form 4 insider trades.
Insider Ownership Summary of John David Harris
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PSTV | Plus Therapeutics Inc | 2016-08-10 | VP and GM of Cell Therapy |
John David Harris Latest Holdings Summary
John David Harris currently owns a total of 1 stock. John David Harris owns 14 shares of Plus Therapeutics Inc (PSTV) as of August 10, 2016, with a value of $18.
Latest Holdings of John David Harris
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PSTV | Plus Therapeutics Inc | 2016-08-10 | 14 | 1.29 | 18 |
Holding Weightings of John David Harris
John David Harris Form 4 Trading Tracker
According to the SEC Form 4 filings, John David Harris has made a total of 0 transactions in Plus Therapeutics Inc (PSTV) over the past 5 years. The most-recent trade in Plus Therapeutics Inc is the acquisition of 5 shares on August 10, 2016, which cost John David Harris around $5,075.
Insider Trading History of John David Harris
- 1
John David Harris Trading Performance
GuruFocus tracks the stock performance after each of John David Harris's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John David Harris is -14.72%. GuruFocus also compares John David Harris's trading performance to market benchmark return within the same time period. The performance of stocks bought by John David Harris within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John David Harris's insider trading performs compared to the benchmark.
Performance of John David Harris
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.27 | | | | | |
| Relative Return to S&P 500(%) | 1.57 | | | | | |
John David Harris Ownership Network
Ownership Network List of John David Harris
Ownership Network Relation of John David Harris
John David Harris Owned Company Details
What does Plus Therapeutics Inc do?
Who are the key executives at Plus Therapeutics Inc?
John David Harris is the VP and GM of Cell Therapy of Plus Therapeutics Inc. Other key executives at Plus Therapeutics Inc include President Marc H Hedrick , Chief Financial Officer Sims Andrew John Hugh Macintyre , and CHIEF MEDICAL OFFICER Norman D. Lafrance .
Plus Therapeutics Inc (PSTV) Insider Trades Summary
Over the past 18 months, John David Harris made no insider transaction in Plus Therapeutics Inc (PSTV). Other recent insider transactions involving Plus Therapeutics Inc (PSTV) include a net purchase of 28,761 shares made by Robert P Lenk , a net purchase of 22,797 shares made by Howard Clowes , and a net purchase of 44,755 shares made by Greg Petersen .
In summary, during the past 3 months, insiders sold 0 shares of Plus Therapeutics Inc (PSTV) in total and bought 39,883 shares, with a net purchase of 39,883 shares. During the past 18 months, 2,068 shares of Plus Therapeutics Inc (PSTV) were sold and 140,755 shares were bought by its insiders, resulting in a net purchase of 138,687 shares.
Plus Therapeutics Inc (PSTV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Plus Therapeutics Inc Insider Transactions
John David Harris Mailing Address
Above is the net worth, insider trading, and ownership report for John David Harris. You might contact John David Harris via mailing address: 3020 Callan Road, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
